Get started
Author

P. Radziszewski

Observed names: P. RADZISZEWSKI, P.R. Radziszewski, Piotr Radziszewski
OpenAlex ID: A5110003046
Safety and tolerability of the β3‐adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12‐week randomised Phase III trials and of a 1‐year randomised Phase III trial
2014 · V. W. Nitti, C. R. Chapple, et al. · International Journal of Clinical Practice · 85
PDF
774 DOSE-RANGING STUDY OF ONCE-DAILY MIRABEGRON (YM178), A NOVEL SELECTIVE β3-ADRENOCEPTOR AGONIST, IN PATIENTS WITH OVERACTIVE BLADDER (OAB)
2010 · C. Chapple, J.J. Wyndaele, et al. · European Urology Supplements · 46
Botulinum toxin type A intravesical injections for intractable bladder overactivity
2002 · P. Radziszewski, A. Borkowski · European Urology Supplements · 34
Significance of Urodynamic Assessment of Lower Urinary Tract in Dialysis Patients Before Renal Transplantation
2007 · A. Chmura, A. Borkowski, et al. · Transplantation Proceedings · 13
Analysis of Long-term Pelvic Floor Electrostimulation Therapy for Interstitial Cystitis
2006 · M. Parsons, P. De Jong, et al. · European Urology Supplements · 6
Refining BCG ‐failure classifications in non‐muscle‐invasive bladder cancer
2026 · Aleksander Ślusarczyk, Pietro Scilipoti, et al. · British Journal of Urology · 5
Predictors and prognostic implications of clinical decisions in patients with primary high-risk non-muscle-invasive bladder cancer – results of a cross country retrospective study
2018 · S. POLETAJEW, R. BIERNACKI, et al. · Neoplasma · 5
PDF
401 The incidence of antimuscarinic-associated side effects in overactive bladder (OAB) patients treated with mirabegron: Results of a pooled analysis of 3 randomised phase 3 trials
2013 · V. Nitti, C.R. Chapple, et al. · European Urology Supplements · 3
C13 Influence of Botulinum Toxin (btx) on the Chemical Coding of Dorsal Root Ganglia (drg) Neurons Supplying Porcine Urinary Bladder - Comparison With Changes Induced by Resiniferatoxin (rtx) and Tetrodotoxin (ttx)
2010 · A. Bossowska, E. Lepiarczyk, et al. · European Urology Supplements · 3
Comparison of conantokin G (CTG)-induced changes in the chemical coding of dorsal root ganglia (DRG) neurons supplying porcine urinary bladder with changes induced by resiniferatoxin (RTX), tetrodotoxin (TTX) and botulinum toxin A (BTX)
2014 · A. Bossowska, E. Lepiarczyk, et al. · European Urology Supplements · 2
741 Pivotal phase 3 study in overactive bladder (OAB) patients with urinary incontinence confirms onabotulinumtoxinA 100U significantly improves all OAB symptoms and patients' quality of life
2013 · C. Chapple, K-D. Sievert, et al. · European Urology Supplements · 2
C14 the Influence of Botulinum Toxin (btx), Tetrodotoxin (ttx) and O-conotoxin Giva (ctx) on the Cholinergic (parasympathetic) Innervation Pattern of the Porcine Urinary Bladder Wall
2010 · E. Lepiarczyk, A. Bossowska, et al. · European Urology Supplements · 2
Effect of Botulinum Toxin (btx) on the Chemical Coding of Nerve Fibres Supplying the Canine Urinary Bladder
2010 · Sylwia Lew, A. Bossowska, et al. · 2
C21 Botulinum toxin (BTX)- and guanethidine-induced changes at chemical coding of paracervical ganglion (PCG) neurons supplying porcine urinary bladder
2009 · A. Bossowska, E. Lepiarczyk, et al. · European Urology Supplements · 2
426 Possible role of matrix metalloproteinase-8 in pathophysiology of interstitial cystitis/painful bladder syndrome
2016 · T. Piecha, S. Poletajew, et al. · European Urology Supplements · 1
C83 Interobserver variability of Clavien-Dindo scoring in urology
2013 · S. Poletajew, S. Piotrowicz, et al. · European Urology Supplements · 1
9 Efficacy of Acute Cystitis Treatment Measured With Immune Parameters
2007 · B. Dvbowski, O. Jablonska, et al. · European Urology Supplements · 1
Pyuria can be prognostic marker for poor oncological outcome prior TUR-BT
2018 · D. Gajewska, K. Kaczmarek, et al. · European Urology Supplements
Men have an increased incidence of high stage bladder cancer
2018 · D. Gajewska, K. Kaczmarek, et al. · European Urology Supplements
Adjuvant immunotherapy after cystectomy for MIBC patients: Lessons learned from the phase II clinical trial ‘Magnolia’
2018 · P.F.A. Mulders, M. Colombel, et al. · European Urology Supplements
Evolution of catheter-associated bacterial flora in patients with benign prostatic hyperplasia – a 20-year perspective
2018 · B. Dvbowski, P. Zapała, et al. · European Urology Supplements
Analysis of methods and results of urolithiasis treatment in patients after push-up procedure
2016 · N. Miązek, I. Michałek, et al. · European Urology Supplements
Evolution of bacterial resistance in patients with indwelling catheters for benign prostatic hyperplasia - 20 year perspective
2016 · P. Zapała, B. Dybowski, et al. · European Urology Supplements
Identification of patients who benefit most from restaging resection of bladder cancer
2016 · Ł. Białek, P. Zapała, et al. · European Urology Supplements
Early survival in bladder cancer patients following cystectomy: A prospective study
2016 · M. Patyk, O. Kuczkiewicz, et al. · European Urology Supplements
Works count: 50
Citation count: 213
H-index: 5
I10-index: 4
Year
Topic
Type